Ethyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetate, 97%, 5g

4-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)benzoic acid, 95.0%, 5g

(R)-1-(3,4-Dichlorophenyl)ethanamine hydrochloride, 95.0%, 2.5g

trans-1,2-Bis[5-(trimethylstannyl)thiophen-2-yl]ethene>98.0%(HPLC)1g

3-(1-Methyl-1H-indol-3-yl)propanenitrile, 250mg

6-Bromoquinolin-3-ol, 95.0%, 1g

4-Nitrophenyl alpha-D-Galactopyranoside [Substrate for alpha-D-Galactosidase]>98.0%(HPLC)200mg

Fmoc-Dap(Boc)-OH, 95%, 25g

2-Cyclopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

9,9-Dimethyl-9H-fluorene, 95.0%, 10g

4-(chloromethyl)-2,6-dihydroxybenzaldehyde, 95.0%, 500mg

4-(4-(Bicyclo[2.2.1]heptan-2-yl)piperazin-1-yl)aniline (racemate), 97%, 1g

1-Phenylicosane-1,3-dione, 95.0%, 100g